Clinical Trials · NCT06745284
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
- Phase
- Phase 1
- Recruitment status
- Active Not Recruiting
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 64
- Start date
- Mar 2025
- Locations
- 2 sites, United States
- Primary endpoint
- Absolute change in sleeping metabolic rate (SMR) (measured in a whole room calorimeter) from baseline to first visit a participant reached at least 10% weight loss